<?xml version="1.0" encoding="UTF-8"?>
<p>As discussed in the previous sections lack of MHC-II molecule expression coincides with lack of detectable levels of CIITA. In cancer the transcriptional silencing of 
 <italic>MHC2TA</italic> and resulting extinction of 
 <italic>MHC-II</italic> gene expression is frequently noted (Murphy and Tomasi, 
 <xref ref-type="bibr" rid="B64">1998</xref>; Yazawa et al., 
 <xref ref-type="bibr" rid="B93">1999</xref>; Meissner et al., 
 <xref ref-type="bibr" rid="B53">2008</xref>; Berghuis et al., 
 <xref ref-type="bibr" rid="B1">2009</xref>). The silencing of CIITA is mostly mediated by chromatin modifications involving methylation of DNA and modifications of histones. The lack of CIITA expression in several cancer types is associated with CpG dinucleotide methylation of CIITA-PIV and of CIITA-PIII DNA (Morris et al., 
 <xref ref-type="bibr" rid="B59">2000</xref>; Van den Elsen et al., 
 <xref ref-type="bibr" rid="B85">2000</xref>, 
 <xref ref-type="bibr" rid="B84">2003</xref>; Van der Stoep et al., 
 <xref ref-type="bibr" rid="B89">2002b</xref>; Holling et al., 
 <xref ref-type="bibr" rid="B29">2004</xref>, 
 <xref ref-type="bibr" rid="B31">2006</xref>; Morimoto et al., 
 <xref ref-type="bibr" rid="B57">2004</xref>; Satoh et al., 
 <xref ref-type="bibr" rid="B73">2004</xref>; De Lerma Barbaro et al., 
 <xref ref-type="bibr" rid="B10">2008</xref>; Meissner et al., 
 <xref ref-type="bibr" rid="B53">2008</xref>). Besides CpG dinucleotide methylation, the lack of IFNÎ³-induced transcription of 
 <italic>MHC2TA</italic> is also associated with histone deacetylase activities (Magner et al., 
 <xref ref-type="bibr" rid="B44">2000</xref>; Murphy et al., 
 <xref ref-type="bibr" rid="B63">2002</xref>; Holtz et al., 
 <xref ref-type="bibr" rid="B32">2003</xref>; Kanaseki et al., 
 <xref ref-type="bibr" rid="B36">2003</xref>; Chou et al., 
 <xref ref-type="bibr" rid="B8">2005</xref>).
</p>
